2022 recap: Dr. Chi highlights milestones in stone disease

Video

“We've got a lot of movement in terms of understanding how stones form, some pharmaceutical interventions that we can use to prevent stones, and then how we can get even less invasive to try to get stones in the least morbid way for our patients,” says Thomas Chi, MD.

Urology Times® is wrapping up the year by diving into some milestones from different urologic specialties. In this interview, Thomas Chi, MD, recaps some of the clinical and research highlights in stone disease from the past year. Chi is a professor and associate chair at the University of California, San Francisco.

Recent Videos
Blurred interior of hospital | Image Credit: © jakkapan - stock.adobe.com
Human kidney cross section on science background | Image Credit: © Crystal light - stock.adobe.com
Katherine Chan, MD, MPH, answers a question during a Zoom virtual interview
John Michael DiBianco, MD, answers a question during a Zoom video interview
Human kidney cross section on science background | Image Credit: © Crystal light - stock.adobe.com
Katherine Chan, MD, MPH, answers a question during a Zoom video interview
Human kidney cross section on scientific background | Image Credit: © Crystal light - stock.adobe.com
Katherine Chan, MD, MPH, gives an answer during a Zoom video interview
Related Content
© 2024 MJH Life Sciences

All rights reserved.